Boston Scientific (BSX) Misses Q1 EPS by 1c, Revenues Miss; Updates 2Q & FY19 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Boston Scientific (BSX) Misses Q1 EPS by 1c, Revenues Miss; Updates 2Q & FY19 EPS Guidance

Boston Scientific (BSX) Receives FDA Approval for LOTUS Edge Aortic Valve System

April 23, 2019 5:18 PM EDT

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System. Delivered via a minimally-invasive procedure, this transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery.

"Bringing the much-anticipated LOTUS Edge valve system to market allows us to provide patients who aren't good candidates for traditional surgery a... More